| Literature DB >> 33839710 |
Agus Dwi Susanto1, Paulus Arka Triyoga2, Fathiyah Isbaniah1, Aulya Fairuz3, Hans Cendikiawan4, Ferdynand Zaron4, Intan Aryanti4, Sarah Naura Irbah3, Moulid Hidayat5.
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus that causes coronavirus diseases 2019 (COVID-19). The SARS-CoV-2 is very contagious and nobody is known to be immune to it. The post-infected lung would leave a scar known as fibrosis, a scar tissue. A study from Wuhan, China suggested the development of fibrosis, though it was too early to label these lung changes as irreversible fibrosis in a time range of 3 weeks. The occurrence of fibrosis indicates a chronic infection which greatly contributes to the hallmark symptom of COVID-19 induced ARDS such as shortness of breath and chest pain. However, many of those studies have not yet explained the condition of the patient's lung after total recovery from the COVID-19. This report demonstrates the clinical symptoms, chest CT scan, spirometry, and blood gas analysis of patient after total recovery from the COVID-19 with appearance lung fibrosis. Copyright (c) 2021 Agus Dwi Susanto, Paulus Arka Triyoga , Fathiyah Isbaniah, Aulya Fairuz, Hans Cendikiawan , Ferdynand Zaron, Intan Aryanti, Sarah Naura Irbah, Moulid Hidayat.Entities:
Keywords: COVID-19; lung fibrosis; recovery
Year: 2021 PMID: 33839710 DOI: 10.3855/jidc.13686
Source DB: PubMed Journal: J Infect Dev Ctries ISSN: 1972-2680 Impact factor: 0.968